/
/
/

Sandu Pharmaceuticals Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)36.36
Volume (₹)210.00
High (₹)37.10
Upper Circuit44.52
Low (₹)36.36
Lower Circuit29.68
Prev Close37.10
52W High (₹)50.00
Price37.10
52W Low (₹)30.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)35.84 Cr
Div. Yield (%)2.70
PE Ratio20.24
Debt to Equity0.00
Price to Book0.84
Book Value36.48
EPS (TTM)1.83
Face Value10.00
ROE (%)5.14

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
SANDUPHQ-XNSE
LTP
1W Low
1W High
Market cap (₹)
1870.7+35.2 (1.92%)
1835.50
1890.40
4,47,476Cr
9614+247 (2.64%)
9305.95
9629
2,54,764Cr
4994.55+190.3 (3.96%)
4864.80
4999.80
1,89,423Cr
1169.7+16.7 (1.45%)
1152
1178.05
1,16,658Cr
1380+8.55 (0.62%)
1364
1404.35
1,11,484Cr
2045.6+90.35 (4.62%)
1964.50
2050
1,09,943Cr
2464.85+146.85 (6.34%)
2302.30
2492.65
1,01,712Cr
1207.55+36.45 (3.11%)
1186.20
1221.60
1,01,005Cr
1735+0 (0.00%)
1690
1739.60
99,253Cr
2089.5-55.2 (-2.57%)
2084.50
2129.85
96,031Cr
37.1+0.1 (0.27%)
36.36
38.35
36Cr

Key Highlights of Sandu Pharmaceuticals Ltd Balance Sheet

Sandu Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹9.66Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹9.66Cr, and the reserves and surplus of the company is ₹34.01Cr.

The company has its non-current liabilities with total liabilities of ₹55.87Cr as of 2026-03-31.

The current liabilities are ₹10.42Cr as of 2026-03-31. At the same time, current assets are ₹25.32Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹12.3Cr and tangible assets of ₹18.12Cr, provided in the Sandu Pharmaceuticals Ltd financial statements.